Is ProFunds Biotechnology stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, ProFunds Biotechnology pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Monday 21st of December 2020 were paid $8.074 per share. Over the last 6 times between 2013 and 2020, ProFunds Biotechnology has paid $25.4565 with an average of $4.24 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for ProFunds Biotechnology 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $39.33, you would have made a profit of $2.17 per share or 5.52%
We do not have enough data to give you this answer.
ProFunds Biotechnology has N/A of the business financed by loans. This puts the company at N/A risk in periods of high inflation where borrowing costs usually go up. With a N/A cash flow to debt ratio of 0, the company's ability to pay off the debt is N/A. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for ProFunds Biotechnology to be low [0 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.